Detalhe da pesquisa
1.
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med;
388(2): 117-127, 2023 01 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36331190
2.
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation;
2024 Apr 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38583093
3.
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.
J Am Soc Nephrol;
35(2): 202-215, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38082486
4.
Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients.
Lancet;
401(10393): 2041-2050, 2023 06 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37156250
5.
Dexamethasone in Hospitalized Patients with Covid-19.
N Engl J Med;
384(8): 693-704, 2021 Feb 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32678530
6.
The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts.
J Am Soc Nephrol;
34(3): 482-494, 2023 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36857500
7.
Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses.
Circulation;
146(20): 1507-1517, 2022 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36314129
8.
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
N Engl J Med;
383(21): 2030-2040, 2020 Nov 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33031652
9.
UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE.
BMC Nephrol;
24(1): 310, 2023 10 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37880609
10.
Conventional and Genetic Evidence on the Association between Adiposity and CKD.
J Am Soc Nephrol;
32(1): 127-137, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33127858
11.
UMOD-ulating CKD risk: untangling the relationship between urinary uromodulin, blood pressure, and kidney disease.
Kidney Int;
100(6): 1168-1170, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34802557
12.
Development and Internal Validation of a Risk Score to Detect Asymptomatic Carotid Stenosis.
Eur J Vasc Endovasc Surg;
61(3): 365-373, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33422437
13.
In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.
Ann Intern Med;
173(4): JC17, 2020 08 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32805174
14.
In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.
Ann Intern Med;
173(4): JC16, 2020 08 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32805175
15.
Blood pressure and kidney disease: chicken or egg (or both)?
Kidney Int;
98(3): 547-549, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32828236
16.
Ambulatory blood pressure monitoring and mortality - Authors' reply.
Lancet;
403(10429): 812, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38431351
17.
Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank.
Int J Obes (Lond);
44(11): 2256-2266, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32678323
18.
Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial.
Eur Heart J;
45(8): 629-631, 2024 Feb 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37793132
19.
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.
Circulation;
138(15): 1505-1514, 2018 10 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30002098
20.
Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease.
Stat Med;
38(22): 4218-4239, 2019 09 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31338848